Insiders Aren’t Buying Pfizer Stock, and That Could Help
Pfizer stock hovers around the $26 level as insiders aren’t buying Pfizer stock. Analysts point to a patient, value-f...
This guide compares region-focused ETFs to highlight which region pays the highest dividend and what factors influence payouts.
21,913 articlesPfizer stock hovers around the $26 level as insiders aren’t buying Pfizer stock. Analysts point to a patient, value-f...
Strategy transferred 411.48 BTC to Coinbase on May 29, 2026, a tiny slice of its huge stake. The move sparks renewed ...
With market volatility on the rise, investors are turning to high-yield dividend plays. Three U.S. names stand out fo...
A rising demand for care and resilient cash flow could make a top medical devices firm a lasting anchor for a long-te...
Pfizer is quietly building a GLP-1 obesity pipeline that could alter the competitive landscape, while investors seek ...
A relatively small stock move can reveal big shifts in the lodging REIT world. See why an $8 million sale of Park Hot...
Strategy faces a tough trade-off: use cash to back STRC dividends and buy Bitcoin, or raise fresh capital that dilute...
Looking for a few durable holdings to anchor a decades-long portfolio? Here are three monster stocks hold next—giants...
Strategy’s perpetual preferred stock has fallen from the $100 issuance price to the mid-$70s, prompting widespread in...
When a large investor opens million position in an industrial REIT, it signals confidence in long-term cash flow and ...
Investors woke up to a move in Comcast shares after strategic news and improving fundamentals. This article breaks do...
Friday brought a sharp move for algonquin power utilities stock as investors digested a guidance miss for 2027. This ...